Laboratorios Farmaceuticos Rovi, S.A.
MSE:ROVI.MC
65.75 (EUR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 829.509 | 817.698 | 648.677 | 419.961 | 381.313 | 303.203 | 275.649 | 265.166 | 246.009 | 238.047 | 217.587 | 201.923 | 184.706 | 158.645 | 115.157 | 127.544 | 100.71 | 78.629 | 7,846,545.204 | 7,051.474 |
Cost of Revenue
| 337.224 | 298.085 | 263.855 | 178.652 | 166.606 | 128.612 | 108.135 | 112.024 | 97.075 | 94.578 | 84.895 | 75.513 | 69.439 | 62.821 | 50.322 | 40.255 | 32.928 | 25.992 | 0 | 7,642.001 |
Gross Profit
| 492.285 | 519.613 | 384.822 | 241.309 | 214.707 | 174.591 | 167.514 | 153.142 | 148.934 | 143.469 | 132.692 | 126.41 | 115.267 | 95.824 | 64.835 | 87.289 | 67.782 | 52.637 | 7,846,545.204 | -590.527 |
Gross Profit Ratio
| 0.593 | 0.635 | 0.593 | 0.575 | 0.563 | 0.576 | 0.608 | 0.578 | 0.605 | 0.603 | 0.61 | 0.626 | 0.624 | 0.604 | 0.563 | 0.684 | 0.673 | 0.669 | 1 | -0.084 |
Reseach & Development Expenses
| 24.923 | 23.869 | 27.445 | 23.801 | 29.304 | 32.376 | 21.033 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 16.223 | 12.782 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,034,437.567 | 1,779.865 |
Selling & Marketing Expenses
| 21.754 | 19.993 | 12.713 | 11.409 | 19.529 | 17.354 | 17.468 | 16.488 | 20.958 | 16.133 | 17.233 | 18.54 | 0 | 0 | 0 | 0 | 0 | 2,542,543.339 | 0 | 0 |
SG&A
| 37.977 | 19.993 | 12.713 | 11.409 | 19.529 | 17.354 | 17.468 | 16.488 | 20.958 | 16.133 | 17.233 | 18.54 | 0 | 0 | 0 | 0 | 0 | 2,542,543.339 | 2,034,437.567 | 1,779.865 |
Other Expenses
| -5.764 | 243.77 | 190.622 | 152.471 | 151.994 | 139.779 | 131.037 | 108.354 | 106.134 | 99.644 | 89.987 | 86.193 | 96.282 | 69.821 | 50.936 | 33.495 | 2.396 | 1.279 | 769,220.751 | 1,056.122 |
Operating Expenses
| 272.031 | 263.763 | 203.335 | 163.88 | 171.523 | 157.133 | 148.505 | 124.842 | 127.092 | 115.777 | 107.22 | 104.733 | 96.282 | 69.821 | 50.936 | 33.495 | 51.74 | 50.423 | 2,420,378.138 | 2,146.805 |
Operating Income
| 220.254 | 255.848 | 181.574 | 74.682 | 42.843 | 17.458 | 19.009 | 28.3 | 21.842 | 27.692 | 25.472 | 21.677 | 18.985 | 26.003 | 13.899 | 28.32 | 18.438 | 3.493 | 291,589.599 | 625.793 |
Operating Income Ratio
| 0.266 | 0.313 | 0.28 | 0.178 | 0.112 | 0.058 | 0.069 | 0.107 | 0.089 | 0.116 | 0.117 | 0.107 | 0.103 | 0.164 | 0.121 | 0.222 | 0.183 | 0.044 | 0.037 | 0.089 |
Total Other Income Expenses Net
| 0.154 | 2.119 | 1.054 | -2.101 | -0.963 | -0.778 | -1.487 | -0.418 | -0.944 | -2.058 | -1.221 | -0.839 | -0.057 | -0.082 | 10.408 | -0.162 | 1.42 | 0.751 | 769,220.751 | 1,034.067 |
Income Before Tax
| 220.408 | 257.967 | 182.628 | 72.581 | 41.88 | 16.68 | 17.522 | 27.882 | 20.898 | 25.634 | 24.251 | 20.838 | 18.928 | 25.921 | 24.307 | 28.158 | 19.858 | 4.244 | 1,060,810.35 | 1,659.861 |
Income Before Tax Ratio
| 0.266 | 0.315 | 0.282 | 0.173 | 0.11 | 0.055 | 0.064 | 0.105 | 0.085 | 0.108 | 0.111 | 0.103 | 0.102 | 0.163 | 0.211 | 0.221 | 0.197 | 0.054 | 0.135 | 0.235 |
Income Tax Expense
| 50.109 | 58.302 | 29.551 | 11.524 | 2.607 | -1.215 | 0.281 | 1.793 | 1.089 | 1.518 | 1.229 | 1.324 | 0.801 | 1.339 | 1.168 | 4.616 | 4.9 | -0.492 | -148,680.006 | 70.762 |
Net Income
| 170.335 | 199.669 | 153.077 | 61.057 | 39.273 | 17.895 | 17.241 | 26.089 | 19.809 | 24.116 | 23.022 | 19.514 | 18.127 | 24.582 | 23.139 | 23.542 | 14.958 | 5.061 | 912,130.345 | 1,582.665 |
Net Income Ratio
| 0.205 | 0.244 | 0.236 | 0.145 | 0.103 | 0.059 | 0.063 | 0.098 | 0.081 | 0.101 | 0.106 | 0.097 | 0.098 | 0.155 | 0.201 | 0.185 | 0.149 | 0.064 | 0.116 | 0.224 |
EPS
| 3.29 | 3.73 | 2.76 | 1.1 | 0.71 | 0.35 | 0.35 | 0.53 | 0.4 | 0.48 | 0.46 | 0.39 | 0.36 | 0.49 | 0.41 | 0.41 | 0.3 | 0.09 | 18,242 | 31.65 |
EPS Diluted
| 3.29 | 3.73 | 2.76 | 1.1 | 0.71 | 0.35 | 0.35 | 0.53 | 0.4 | 0.48 | 0.46 | 0.39 | 0.36 | 0.49 | 0.41 | 0.41 | 0.3 | 0.09 | 18,242 | 31.65 |
EBITDA
| 245.597 | 279.626 | 202.687 | 96.768 | 60.926 | 29.459 | 30.014 | 39.82 | 32.654 | 37.121 | 32.722 | 27.636 | 25.925 | 31.077 | 26.752 | 31.232 | 16.786 | 2.564 | 421,539.939 | 1,726.089 |
EBITDA Ratio
| 0.296 | 0.342 | 0.312 | 0.23 | 0.16 | 0.097 | 0.109 | 0.15 | 0.133 | 0.156 | 0.15 | 0.137 | 0.14 | 0.196 | 0.232 | 0.245 | 0.167 | 0.033 | 0.054 | 0.245 |